Skip to main content


Page 1 of 7

  1. Although reduced work ability is a substantial problem among people with inflammatory arthritis (IA), work ability is an underexposed area in clinical practice. Evidence on vocational interventions in IA is li...

    Authors: N. F. Bakker, S. F. E. van Weely, N. Hutting, Y. F. Heerkens, J. A. Engels, J. B. Staal, M. van der Leeden, A. Boonen, W. B. van den Hout, T. P. M. Vliet Vlieland and J. Knoop
    Citation: BMC Rheumatology 2023 7:31
  2. Cardiac tumours are rare, and clinical manifestations depend on the anatomical location. Symptoms can be the result of cardiac outflow anomalies, constitutional features such as fever, loss of weight, and/or p...

    Authors: Natasha Ung, Carmella Gunasingam, Ken Cai, Nicholas Manolios, Angela Bayly, Phuong Dinh, Yishay Orr, Preeti Choudhary and Peter Wong
    Citation: BMC Rheumatology 2023 7:30
  3. The study aimed to investigate novel biomarkers from the C1q TNF superfamily and evaluate their role in autoimmune inflammatory rheumatic diseases with the goal of identifying an effective biomarker to measure...

    Authors: İ.Merve B. Uçar, Gökhan Sargin, Ayça Tuzcu, Songül Çildağ and Taşkın Şentürk
    Citation: BMC Rheumatology 2023 7:29
  4. To study the risk of osteoporosis-related fractures in a community-based sample of men and women with rheumatoid arthritis (RA) overall, as well as early (< 1 year of disease duration, follow-up time maximum 1...

    Authors: Lisa Theander, Lennart T.H. Jacobsson and Carl Turesson
    Citation: BMC Rheumatology 2023 7:28
  5. Lifestyle physical activity (PA) is defined as any type of PA undertaken as part of daily life. It can include engagement in activities of daily living (i.e., household chores, gardening, walking to work), inc...

    Authors: Sophia M. Brady, Jet J. C. S. Veldhuijzen van Zanten, Petros C. Dinas, Tom E. Nightingale, George S. Metsios, Saleh M. A. Elmsmari, Joan L. Duda, George D. Kitas and Sally A. M. Fenton
    Citation: BMC Rheumatology 2023 7:27
  6. The psychological burden in people with inflammatory arthritis is substantial, yet little is known about the disease-related affect experienced by individuals with axial Spondyloarthritis (axial SpA). The aim ...

    Authors: Nicky Wilson, Jia Liu, Qainat Adamjee, Sonya Di Giorgio, Sophia Steer, Jane Hutton and Heidi Lempp
    Citation: BMC Rheumatology 2023 7:26
  7. Behcet’s disease (BD) is a systemic disease characterized by recurrent oral and genital ulcers. The underlying disease pathway likely involves interleukin (IL)-17 A, a proinflammatory cytokine that is implicat...

    Authors: Frances Sze Kei Sun, Nicole Sau Yan Chiu and Ho Yin Chung
    Citation: BMC Rheumatology 2023 7:25
  8. Antinuclear antibodies (ANA) are antibodies present in several autoimmune disorders. However, a large proportion of the general population (20%) also have a positive test; very few of these individuals will de...

    Authors: Jacy T. Zanussi, Juan Zhao, Wei-Qi Wei, Gul Karakoc, Cecilia P. Chung, QiPing Feng, Nancy J. Olsen, C. Michael Stein and Vivian K. Kawai
    Citation: BMC Rheumatology 2023 7:24
  9. Risk of fragility fractures in patients with rheumatoid arthritis (RA) is increased. Disease-related inflammation in RA is associated with low Bone Mineral Density (BMD). However, effects of specific disease f...

    Authors: Sofia Ajeganova, Maria Andersson, Kristina Forslind, Inger Gjertsson, Britt-Marie Nyhäll-Wåhlin, Björn Svensson and Ingiäld Hafström
    Citation: BMC Rheumatology 2023 7:23
  10. We assessed the risk factors and outcome of COVID-19 in patients with autoimmune rheumatic diseases(AIRD) who contracted infection while on background treatment with tofacitinib.

    Authors: Pramod Chebbi, Vineeta Shobha, Vijay K Rao, Vikram Haridas, Ramya Janardana, Benzeeta Pinto, Sharath Kumar, Abhishek Patil, Roopa Tekkatte, Manasa Salanke and K M Mahendranath
    Citation: BMC Rheumatology 2023 7:22
  11. Poor sleep quality is a common and potentially debilitating problem in systemic sclerosis (SSc). To date, no data clarifies the potential factors related to poor sleep quality and the clinical associations wit...

    Authors: Nonthaphorn Wongthawa, Apichart So-gnern, Ajanee Mahakkanukrauh, Siraphop Suwannaroj and Chingching Foocharoen
    Citation: BMC Rheumatology 2023 7:21
  12. The importance of COVID-19 vaccination for patients on immunosuppressive (IS) medication has increased due to the high risk of severe disease or mortality. Different vaccines have varying efficacy rates agains...

    Authors: Fulya Cosan, Ozlem Unay Demirel, Demet Yalcin, Muhammed Mert Sonkaya, Isilsu Ezgi Uluisik, Olida Cecen, Yavuz Furuncuoglu, Deniz Maktav Celikmen, Osman Kara, Erkan Ceylan and Timucin Avsar
    Citation: BMC Rheumatology 2023 7:20
  13. This paper estimates spatial inequalities of Rheumatoid Arthritis (RA) in Colombia and explores correlates of those disparities from a health system perspective.

    Authors: Norman Maldonado, Sandra Camacho, Sergio I. Prada, Andrés Hormaza-Jaramillo, Victoria Soto, William García, Nelcy Paredes and Fabián Cardona
    Citation: BMC Rheumatology 2023 7:19
  14. VEXAS is a recently described inflammatory disease caused by mutations in the UBA1 gene. Symptoms are diverse and include fevers, cartilaginous inflammation, lung inflammation, vasculitis, neutrophilic dermatoses...

    Authors: Khiem T. Vu, Rachel M. Wolfe, Jonathan E. Lambird and Danielle L. V. Maracaja
    Citation: BMC Rheumatology 2023 7:18
  15. Early assessment of patient preferences has the potential to support shared decisions in personalized precision medicine for patients with rheumatoid arthritis (RA). The aim of this study was to assess treatme...

    Authors: Karin Schölin Bywall, Bente Appel Esbensen, Marie Heidenvall, Inger Erlandsson, Marta Lason, Mats Hansson and Jennifer Viberg Johansson
    Citation: BMC Rheumatology 2023 7:17
  16. Systemic lupus erythematosus (SLE) is a chronic autoimmune disease which impacts patients’ lives. Many studies in high-income countries have focused on their health-related quality of life (HRQoL). However, ev...

    Authors: Aya Mizukami, Minh Trang Trinh, Thi Phuong Hoang, Akira Shibanuma, Ken Ing Cherng Ong and Masamine Jimba
    Citation: BMC Rheumatology 2023 7:16
  17. Gout is the most common inflammatory arthritis, increasing in prevalence and burden. Of the rheumatic diseases, gout is the best-understood and potentially most manageable condition. However, it frequently rem...

    Authors: Brooke Conley, Samantha Bunzli, Jonathan Bullen, Penny O’Brien, Jennifer Persaud, Tilini Gunatillake, Michelle M Dowsey, Peter F Choong, Mandana Nikpour, Rebecca Grainger and Ivan Lin
    Citation: BMC Rheumatology 2023 7:15
  18. Air pollution is a key public health factor with the capacity to induce diseases. The risk of ischemia heart disease (IHD) in those suffering from systemic lupus erythematosus (SLE) from air pollution exposure...

    Authors: Pei-Yun Chen, Yu-Tse Tsan, Chao-Tung Yang, Yun-Mei Lee, Li-Li Chen, Wen-Chao Ho and Shu-Hua Lu
    Citation: BMC Rheumatology 2023 7:14
  19. The inability to assess structural changes in facet joints is a limitation of established radiographic scoring systems for ankylosing spondylitis (AS). We compared radiographic evidence of ankylosis in cervica...

    Authors: Tae-Han Lee, Seunghun Lee, Bon San Koo, Kyung Bin Joo and Tae-Hwan Kim
    Citation: BMC Rheumatology 2023 7:11
  20. The novel Coronavirus disease (COVID-19) pandemic has represented an evolving global threat with high morbidity and mortality. Patients with autoimmune rheumatic diseases and on immune-suppressing medications ...

    Authors: Nicole K. Zagelbaum Ward, Suman Pal, Katherine Ruddy and Stavros Savvas
    Citation: BMC Rheumatology 2023 7:13
  21. Patient and public involvement is an idea whose time has firmly come. It is the views of these Guest Editors that it is the right thing to do morally and improves research quality and applicability.

    Authors: Angie Botto-van Bemden, Adewale O. Adebajo and Ciarán Martin Fitzpatrick
    Citation: BMC Rheumatology 2023 7:12
  22. Flare-up of systemic lupus erythematosus (SLE) is a common characteristic that could have deleterious effects on patients’ outcome and survival. The aim of this study was to identify the predictors of severe l...

    Authors: Alimohammad Fatemi, Elaheh Keivani-Boroujeni and Abbas Smiley
    Citation: BMC Rheumatology 2023 7:10
  23. Systemic sclerosis (SSc) is a rare autoimmune disorder characterized by vascular and fibrosing involvement of the skin and internal organs. In this study, we determined the prevalence and characteristics of ra...

    Authors: Fatemeh Badiee, Alireza Fatemi, Reza Zahedpasha, Mohammad Hadi Gharib, Mohammadhassan Jokar, Somayeh Livani, Mehrdad Aghaie and Nafiseh Abdolahi
    Citation: BMC Rheumatology 2023 7:9
  24. Drug-related problems can negatively influence treatment outcome and well-being for patients with rheumatic diseases. Thus, it is important to support patients in preventing or resolving drug-related problems ...

    Authors: Lex L. Haegens, Victor J. B. Huiskes, Elisabeth M. Smale, Charlotte L. Bekker and Bart J. F. van den Bemt
    Citation: BMC Rheumatology 2023 7:7
  25. The nature of the deposits in immune-mediated glomerulonephritis with a membranous pattern and masked IgG-Kappa deposits (MGMID) remains still to be elucidated.

    Authors: Savino Sciascia, Paolo Miraglia, Massimo Radin, Manuela Giarin, Nicolas Charbonier, Antonella Barreca, Irene Cecchi, Irene Lanzetta, Roberta Fenoglio, Elisa Menegatti and Dario Roccatello
    Citation: BMC Rheumatology 2023 7:6
  26. Biologic therapies are often prescribed for patients with rheumatoid arthritis (RA) who have inadequate responses to or are intolerant of methotrexate (MTX) and patients with poor prognostic indicators. This p...

    Authors: Aaron Broadwell, Joy Schechtman, Douglas Conaway, Alan Kivitz, Natalie J. Shiff, Shawn Black, Stephen Xu, Wayne Langholff, Sergio Schwartzman and Jeffrey R. Curtis
    Citation: BMC Rheumatology 2023 7:5
  27. The effects and their magnitudes of sex on disease activity indices for rheumatoid arthritis are not clear. We aimed to comprehensively evaluate the influence of sex on disease activity indices in the real-wor...

    Authors: Takahiro Nishino, Atsushi Hashimoto, Shigeto Tohma and Toshihiro Matsui
    Citation: BMC Rheumatology 2023 7:4
  28. Patient and public involvement (PPI) in every aspect of research will add valuable insights from patients’ experiences, help to explore barriers and facilitators to their compliance/adherence to assessment and...

    Authors: Ashokan Arumugam, Lawrence Rick Phillips, Ann Moore, Senthil D. Kumaran, Kesava Kovanur Sampath, Filippo Migliorini, Nicola Maffulli, Bathri Narayanan Ranganadhababu, Fatma Hegazy and Angie Botto-van Bemden
    Citation: BMC Rheumatology 2023 7:2
  29. Aotearoa New Zealand (AoNZ) has no agreed models for rheumatology service provision in government-funded health care. We aimed to describe what people with inflammatory rheumatic diseases who have used rheumat...

    Authors: Rachel Ngan Kee, Valerie Milne, Nicola Dalbeth and Rebecca Grainger
    Citation: BMC Rheumatology 2023 7:1
  30. Rheumatoid arthritis (RA) is the most common form of autoimmune arthritis, but the prevalence in Australia is unknown. We estimated RA period prevalence and identified factors associated with frequent RA hospi...

    Authors: Khalid Almutairi, Charles Inderjeeth, David B Preen, Helen Keen and Johannes Nossent
    Citation: BMC Rheumatology 2022 6:93
  31. Systemic lupus erythematosus or lupus is a severe chronic autoimmune disorder that disproportionately impacts young African Americans. Increasing lupus awareness in this high-risk group may be an effective app...

    Authors: Edith M. Williams, Joni Nelson, Diane Francis, Keesha Corbin, Gary Link, Tomika Caldwell and Gary Gilkeson
    Citation: BMC Rheumatology 2022 6:92
  32. Bone erosions may appear early or later during rheumatoid arthritis (RA), causing joint damage and functional impairment. However, in some patients erosions do not occur, even after several years of disease. T...

    Authors: Björn Svensson, Maria L. E. Andersson, Inger Gjertsson, Ingiäld Hafström, Sofia Ajeganova and Kristina Forslind
    Citation: BMC Rheumatology 2022 6:88
  33. COVID-19 is associated with a postinfectious hyperinflammatory disorder, multisystem inflammatory syndrome in children (MIS-C), that shares characteristics with still’s disease, known as systemic juvenile idio...

    Authors: Maya Alexandri, Julisa Patel, Eli Paul and Lynne W. Coule
    Citation: BMC Rheumatology 2022 6:87
  34. To determine whether there were improvements in rheumatology care for rheumatoid arthritis (RA) between 2002 and 2019 in Ontario, Canada, and to evaluate the impact of rheumatologist regional supply on access.

    Authors: Claire E. H. Barber, Diane Lacaille, Ruth Croxford, Cheryl Barnabe, Deborah A. Marshall, Michal Abrahamowicz, Hui Xie, J. Antonio Avina-Zubieta, John M. Esdaile, Glen Hazlewood, Peter Faris, Steven Katz, Paul MacMullan, Dianne Mosher and Jessica Widdifield
    Citation: BMC Rheumatology 2022 6:86
  35. Although drug treatment strategies for rheumatoid arthritis (RA) are relatively well established, there is a paucity of evidence on the treatment in older patients. The purpose of this study is to build a regi...

    Authors: Masayo Kojima, Yutaka Kawahito, Takahiko Sugihara, Toshihisa Kojima, Ryozo Harada, Shintaro Hirata, Motomu Hashimoto, Toshihiko Hidaka, Hajime Ishikawa, Hiromu Ito, Mitsumasa Kishimoto, Yuko Kaneko, Kazuo Matsui, Toshihiro Matsui, Isao Matsushita, Akio Morinobu…
    Citation: BMC Rheumatology 2022 6:90
  36. Biologic and targeted synthetic disease modifying agents (b/tsDMARDs) have broadened the treatment landscape for autoimmune diseases particularly in patients refractory to conventional DMARDs. More recently, t...

    Authors: Thomas Khoo, Navkiran Sidhu, Franca Marine, Susan Lester, Alannah Quinlivan, Debra Rowett, Rachelle Buchbinder and Catherine L. Hill
    Citation: BMC Rheumatology 2022 6:79
  37. Rheumatoid arthritis (RA) is commonly associated with higher rates of comorbidities. Recent recommendations highlight screening comorbidities during the disease course because of their impact on patients’ abil...

    Authors: Aicha Ben Tekaya, Emna Hannech, Olfa Saidane, Leila Rouached, Selma Bouden, Rawdha Tekaya, Ines Mahmoud and Leila Abdelmoula
    Citation: BMC Rheumatology 2022 6:78
  38. The outbreak of severe acute respiratory syndrome coronavirus 2 has had an enormous impact on global health. Vaccination remains one of the most effective interventions for disease prevention. Clinically signi...

    Authors: Meghan Corrigan Nelson, Heather Rytting, Larry A. Greenbaum and Baruch Goldberg
    Citation: BMC Rheumatology 2022 6:81
  39. Assessing medication adherence in rheumatoid arthritis (RA) is clinically significant as low adherence is associated with high disease activity. Self-reported medication adherence surveys have been shown to ha...

    Authors: Nobuyuki Yajima, Takashi Kawaguchi, Ryo Takahashi, Hiroki Nishiwaki, Yoichi Toyoshima, Koei Oh, Tsuyoshi Odai, Takayuki Kanai, Donald E. Morisky, Takuhiro Yamaguchi and Tsuyoshi Kasama
    Citation: BMC Rheumatology 2022 6:75
  40. Some composite measures for determining the treatment effects of disease-modifying antirheumatic drugs on remission and low disease activity (LDA) in rheumatoid arthritis (RA) may produce misleading results if...

    Authors: Kirsten Janke, Corinna Kiefer, Natalie McGauran, Bernd Richter, Dietmar Krause and Beate Wieseler
    Citation: BMC Rheumatology 2022 6:82
  41. This study evaluated the existence of anti-drug antibodies (ADAs) before and 52 weeks after switching from intravenous infliximab (IFX) to intravenous CT-P13 in patients with rheumatoid arthritis (RA).

    Authors: Hideo Sakane, Koichi Okamura, Makoto Inoue, Hiroshi Inoue, Yukio Yonemoto, Hirofumi Mitomi, Kosei Tsuchida, Takahito Suto, Tetsuya Kaneko and Hirotaka Chikuda
    Citation: BMC Rheumatology 2022 6:74
  42. Rituximab (RTX), anti-CD 20 monoclonal antibodies, has been approved for many rheumatic and autoimmune diseases, the use of RTX is still limited due to financial constrain. Biosimilar RTX may increase access b...

    Authors: Wanruchada Katchamart, Pintip Ngamjanyaporn, Annop Orawongpaisarn, Thossapoom Phubangkertphon, Sasimon Borrirukwisitsak and Nichapa Dechapaphapitak
    Citation: BMC Rheumatology 2022 6:77
  43. The use of frequent electronic patient reported outcome measures (ePRO’s) enables monitoring disease activity at a distance (telemonitoring) in patients with inflammatory arthritis. However, telemonitoring stu...

    Authors: J. Wiegel, B. F. Seppen, M. T. Nurmohamed, W. H. Bos and M. M. ter Wee
    Citation: BMC Rheumatology 2022 6:73
  44. Although patients with rheumatic and musculoskeletal diseases (RMDs) are at increased risk for adverse outcomes of COVID-19 illness compared to healthy controls, they also have lower rates of willingness to be...

    Authors: Yomei P. Shaw, Sara Hustek, Nina Nguyen, Makenzie Starlin, Kristin Wipfler, Beth I. Wallace and Kaleb Michaud
    Citation: BMC Rheumatology 2022 6:76
  45. Involving patients and members of the public in healthcare planning is beneficial for many reasons including that the outcomes focus on topics relevant to service users. The National Early Inflammatory Arthrit...

    Authors: Sarah Oyebanjo, Paul Amlani-Hatcher, Ruth Williams, Roger Stevens, Tom Esterine, Kate Wilkins, Clare Jacklin, Jill Hamilton, Rosie Fairfax and Heidi Lempp
    Citation: BMC Rheumatology 2022 6:89
  46. The 2021 American College of Rheumatology (ACR) rheumatoid arthritis (RA) guideline considers the specific context of the United States which differs from that of Saudi Arabia in many aspects that may impact r...

    Authors: Mohammed A. Omair, Hanan Al Rayes, Joanne Khabsa, Sally Yaacoub, Sultana Abdulaziz, Ghada A. Al Janobi, Abdulaziz Al Khalaf, Bader Al Mehmadi, Mahasin Al Nassar, Faisal AlBalawi, Abdullah S. AlFurayj, Ahmed Hamdan Al-Jedai, Haya Mohammed Almalag, Hajer Yousef Almudaiheem, Ali AlRehaily, Mohammed A. Attar…
    Citation: BMC Rheumatology 2022 6:70
  47. The 28-joint disease activity score (DAS28) is a widely used measure to assess disease activity in rheumatoid arthritis (RA). The DAS28-P index, a derived proportion of the patient-reported components (joint t...

    Authors: Huai Leng Pisaniello, Samuel L. Whittle, Susan Lester, Fiona Menz, Robert Metcalf, Leah McWilliams, Catherine L. Hill and Susanna Proudman
    Citation: BMC Rheumatology 2022 6:67

Annual Journal Metrics

  • 2022 Citation Impact
    2.2 - 2-year Impact Factor
    2.9 - 5-year Impact Factor
    0.891 - SNIP (Source Normalized Impact per Paper)
    0.703 - SJR (SCImago Journal Rank)

    2022 Speed
    18 days submission to first editorial decision for all manuscripts (Median)
    138 days submission to accept (Median)

    2022 Usage 
    1,275 Altmetric mentions 

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal